Ionetix receives FDA approval for Gallium Ga-68 gozetotide ANDA
Ionetix Corporation announced FDA approval of its Abbreviated New Drug Application for Gallium Ga-68 gozetotide, a radioactive diagnostic agent for PSMA-PET imaging in prostate can…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Ionetix Corporation announced FDA approval of its Abbreviated New Drug Application for Gallium Ga-68 gozetotide, a radioactive diagnostic agent for PSMA-PET imaging in prostate can…
Home Depot filed a restated certificate of incorporation that integrates previous amendments without material changes to corporate governance. The filing is a routine administrativ…
Deloitte & Touche LLP consented to incorporate by reference its February 27, 2026 audit report of Vectren Energy Delivery of Ohio, LLC financial statements into multiple Form S-3 a…
Corbus Pharmaceuticals announced updated Phase 1/2 data showing CRB-701 demonstrated robust activity in second-line oropharyngeal and cervical cancers with confirmed response rates…
Microbot Medical announced that Israel's Ministry of Health AMAR Division approved marketing clearance for its LIBERTY Endovascular Robotic System, making Israel the second jurisdi…
Worksport's clean-energy subsidiary Terravis Energy received U.S. Patent No. 12,624,872 for its AetherLux heat-pump system with ZeroFrost technology, designed to address frost buil…
The FDA's Office of New Drugs determined that substantial evidence supports the effectiveness of ONS-5010/LYTENAVA for neovascular age-related macular degeneration following the fo…
D-Wave's subsidiary Quantum Circuits received second-year funding from the U.S. Department of War's Microelectronics Commons program to advance scalable superconducting qubit fabri…
Ares Strategic Income Fund executed a Third Amended and Restated Senior Secured Credit Agreement for $4.1 billion, effective May 21, 2026, with JPMorgan Chase as administrative age…
Editas Medicine presented preclinical data showing EDIT-401 achieved robust ~90% mean reductions in multiple atherogenic lipoproteins in non-human primates with a single dose. The …
U.S. regulators published feedback letters on resolution plans submitted by domestic and foreign banking organizations. The letters provide guidance to help banks improve their pla…
Nuvve Holding Corp. received notice from Nasdaq that it failed to file its Form 10-Q for Q1 2026, violating listing requirements and adding another delisting basis alongside existi…
CNL Strategic Residential Credit, Inc. amended its loan agreement with Valley National Bank to add a $5 million non-formula revolving facility with a maturity date of December 31, …
Global Interactive Technologies (NASDAQ: GITS) received a delinquency compliance alert from Nasdaq on May 21, 2026 for failing to timely file its Form 10-Q for Q1 2026 and remainin…
Laser Photonics received notice from Nasdaq on May 21, 2026 that it is not in compliance with listing rules due to delayed filing of its Q1 2026 quarterly report. The company has 6…
La Rosa Holdings received a deficiency notification from Nasdaq for failing to timely file its Q1 2026 Form 10-Q and 2025 Form 10-K, with a June 15, 2026 deadline to submit a compl…
Lazard amended its certificate of incorporation to transition from a classified board structure to a single-class board with annual elections for all directors beginning in 2027. T…
The FDA approved Hepcludex (bulevirtide-gmod) injection for treating chronic HDV infection in adults without cirrhosis or with compensated cirrhosis. This marks the first FDA-appro…
Atlantic American Corporation received a Nasdaq notice on May 21, 2026 stating the company is not in compliance with listing rules due to delayed Form 10-Q and Form 10-K filings. T…
Everspin Technologies amended and restated its equity incentive plan, expanding stock award types available to employees, directors and consultants. The plan provides flexibility f…